The verdict of the US district court in New Jersey is that Shilpa's generic infringes a US patent on multikinase inhibitor ...

Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...

The only available treatment for a patient with coeliac disease is a strict gluten-free diet, which is often not enough on ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections, and, in ...

Molbreevi – a new inhaled formulation of the well-established and off-patent white blood cell stimulator molgramostim – is ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

In another signal of downgraded support for COVID-19 vaccination programmes under the Trump administration, the CDC has ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

President Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he ...

Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...

In particular, the organisation is unhappy with Kennedy's repeated assertions that Alzheimer's research has been dedicated to ...